Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H24O4 |
Molecular Weight | 364.4343 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)OC1=CC=C(C=C1)C(=C2CCCCC2)C3=CC=C(OC(C)=O)C=C3
InChI
InChIKey=GVOUFPWUYJWQSK-UHFFFAOYSA-N
InChI=1S/C23H24O4/c1-16(24)26-21-12-8-19(9-13-21)23(18-6-4-3-5-7-18)20-10-14-22(15-11-20)27-17(2)25/h8-15H,3-7H2,1-2H3
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/7097643Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/7097643
Sources: http://www.ncbi.nlm.nih.gov/pubmed/7097643
Curator's Comment: description was created based on several sources, including, http://www.ncbi.nlm.nih.gov/pubmed/7097643
Cyclofenil is a anti-estrogen drug developed for the treatment of female infertility and for induction of ovulation. Cyclofenil exerts its action by binding to estrogen receptor beta and demonstrates agonism or antagonism depending on tissues type. The drug was withdrawn from the market due to high risk of hepatotoxicity.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: Q92731|||O75584 Gene ID: 2100.0 Gene Symbol: ESR2 Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/16610793 |
9.4 nM [Kd] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | SEXOVID Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[Comparative clinical studies on clomiphen, cyclofenil and epimestrol (author's transl)]. | 1977 Jun |
|
Efficacy of clomiphene citrate and cyclofenil for infertile women with normal ovulatory cycles. | 2001 Aug |
|
Mass spectrometric analysis of cyclofenil and its metabolites in human urine. | 2002 |
|
Infertility and subfertility. | 2004 Jun |
|
Design and synthesis of functionalized cyclopentadienyl tricarbonylmetal complexes for technetium-94m PET imaging of estrogen receptors. | 2005 Mar-Apr |
|
Fluorine-substituted cyclofenil derivatives as estrogen receptor ligands: synthesis and structure-affinity relationship study of potential positron emission tomography agents for imaging estrogen receptors in breast cancer. | 2006 Apr 20 |
|
Elemental isomerism: a boron-nitrogen surrogate for a carbon-carbon double bond increases the chemical diversity of estrogen receptor ligands. | 2007 Jun |
|
Synthesis and biodistribution of fluorine-18-labeled fluorocyclofenils for imaging the estrogen receptor. | 2007 May |
|
Synthesis of new carbon-11 labeled cyclofenil derivatives for PET imaging of breast cancer estrogen receptors. | 2008 Apr |
|
Fluorimetric determination of cyclofenil using photochemical derivatization. | 2008 Feb 15 |
|
Synthesis and identification of hydroxylated metabolites of the anti-estrogenic agent cyclofenil. | 2008 Jul |
|
Nonclassical SNAPFL analogue as a Cy5 resonance energy transfer partner. | 2008 Nov 6 |
|
Terameprocol, a methylated derivative of nordihydroguaiaretic acid, inhibits production of prostaglandins and several key inflammatory cytokines and chemokines. | 2009 Jan 8 |
|
Monitoring a coordinated exchange process in a four-component biological interaction system: development of a time-resolved terbium-based one-donor/three-acceptor multicolor FRET system. | 2010 Apr 7 |
|
Photocontrol of protein activity in cultured cells and zebrafish with one- and two-photon illumination. | 2010 Mar 22 |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/6424373
600 mg/daily
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C481
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
||
|
WHO-ATC |
G03GB01
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
||
|
WHO-VATC |
QG03GB01
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C78030
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
220-089-1
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
86464
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
m3983
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | Merck Index | ||
|
2983
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | RxNorm | ||
|
Cyclofenil
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
753
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
2624-43-3
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
SUB06852MIG
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
DB13472
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
DTXSID4022866
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
CHEMBL141305
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
J468V64WZ1
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
2898
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
D003506
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
100000083751
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY | |||
|
2258
Created by
admin on Fri Dec 15 16:04:01 GMT 2023 , Edited by admin on Fri Dec 15 16:04:01 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)
METABOLITE (PARENT)